Global trends in indocyanine green fluorescence navigation in the field of gastric cancer: bibliometrics and knowledge atlas analysis
Original Article

Global trends in indocyanine green fluorescence navigation in the field of gastric cancer: bibliometrics and knowledge atlas analysis

Guoyang Zhang1,2#, Yujun Zhang3#, Yiwei Zhang4#, Wentao Zhao5, Yu Xia6, Jingjing Song3, Zongfeng Feng1,2, Li Liu1, Xufeng Shu1, Ahao Wu1, Yukang Wu1, Yi Cao1, Zhigang Jie1, Zhengrong Li1

1Department of Digestive Surgery, Digestive Disease Hospital, the First Affiliated Hospital of Nanchang University, Nanchang, China; 2Medical Innovation Center, the First Affiliated Hospital of Nanchang University, Nanchang, China; 3Jiangxi Medical College of Nanchang University, Nanchang, China; 4Queen Mary College, Nanchang University, Nanchang, China; 5The Third Clinical Department, China Medical University, Shenyang, China; 6The Second Clinical Medical College of Nanchang University, Nanchang, China

Contributions: (I) Conception and design: Z Jie, Z Li; (II) Administrative support: Yujun Zhang; (III) Provision of study materials or patients: Z Jie, Z Li; (IV) Collection and assembly of data: Yujun Zhang; (V) Data analysis and interpretation: L Liu, G Zhang; (VI) Manuscript writing: All authors; (VII) Final approval of manuscript: All authors.

#These authors contributed equally to this work.

Correspondence to: Zhigang Jie, MD; Zhengrong Li, MD. Department of Digestive Surgery, Digestive Disease Hospital, The First Affiliated Hospital of Nanchang University, No. 17 Yongwai Zhengjie, Donghu District, Nanchang 330006, China. Email: jiezg123@126.com; lzr13@foxmail.com.

Background: Indocyanine green (ICG) fluorescence navigation can enhance the visualization of gastric cancer (GC) lesions, increase the lymph node detection rate, and reduce the incidence of anastomotic leakage in the treatment of GC. It thus holds considerable potential for application in GC clinical surgery and has attracted widespread research interest. The purpose of this study was to visualize the current topics and emerging trends in research regarding ICG in GC.

Methods: We searched the Web of Science Core Collection (WoSCC) for articles relevant to the use of ICG in GC. The resulting information was then analyzed from a bibliometric and knowledge graph analysis perspective using CiteSpace, Scimago Graphica, and R Studio so that the key trends and hot spots in research within this field could be identified and visualized.

Results: Ultimately, 1,385 papers from 58 countries or regions published from 1991 to 2022 were included in this study. The largest number of publications were from China, followed by Japan and the United States. High-yield institutions were concentrated in Asian countries, especially China. The top publication contributors were Shanghai Jiao Tong University. Li Y and Bang YJ ranked first among the top 10 most productive authors and top 10 most cocited authors, respectively. World Journal of Gastroenterology was the most productive academic journal on ICG in GC, while Cancer Research was the most commonly cocited journal. The keyword “indocyanine green” was among the top 5 keywords, and will likely remain a popular topic in future research. Furthermore, the emerging themes including surgery, biopsy, lymphadenectomy, dissection, and gastrectomy have attracted increasing attention.

Conclusions: Current research hotspots in this area focus on the clinical implementation of ICG in precision surgery for GC. Given the imaging tracer characteristics of ICG and its utility in GC surgery, the optimization and application of ICG-guided precision surgery techniques for GC will be a research hot spot going forward.

Keywords: Indocyanine green (ICG); gastric cancer (GC); bibliometric analysis; CiteSpace; Web of Science (WoS)


Submitted Mar 25, 2023. Accepted for publication Aug 07, 2023. Published online Aug 23, 2023.

doi: 10.21037/qims-23-391


Introduction

Although the general prevalence of gastric cancer (GC) has declined significantly over the past decades, GC remains one of the leading worldwide healthcare issues, particularly in East Asian countries (1-4), and is the third most common cause of cancer-related death globally, ranking fifth in the incidence rate among cancers (5). According to the incidence and mortality statistics of cancer in China in 2016, the incidence and mortality rate of GC ranked in the top 5 among cancers (6). Previous studies have shown that GC has relatively lower prevalence and incidence rates in younger age groups (under 45 years). However, new evidence indicates that the prevalence of this premature cancer could increase in countries that are low- or high-risk for GC (7-9).

The prognosis of GC is closely associated with the stage of cancer, with the 5-year survival rate of patients at different stages varying greatly (10). Therefore, early diagnosis and treatment of GC are crucial to reducing mortality and improving survival. Integrated operative treatment is the primary tool for managing advanced GC, and lymphadenectomy for GC is considered an important component of the prognosis, staging, and treatment of this disease (11-14). Since Kitano et al. (15) in Japan reported the first case of laparoscopic-assisted distal gastrectomy for the treatment of early GC (EGC) in 1994, the traditional laparoscopic radical gastrectomy technique for GC has been developed for more than 20 years, with its surgical techniques maturing, indications expanding, and postoperative complications decreasing. Due to the growing maturity of traditional laparoscopic technology, a new surgical method of reduced-orifice laparoscopic technology has gradually emerged in recent years. This technique can substantially improve postoperative aesthetic outcomes, decrease postoperative pain, and shorten hospital stay, among other advantages, and both its benefits and drawbacks have been reported in myriad publications.

Despite the availability of these therapeutic modalities for GC, urgent intraoperative issues include precise localization of gastric tumors, sentinel lymph node navigation surgery for EGC, lymphatic drainage guidance for progressive GC, and intraoperative assessment of the anastomotic blood supply. To further address these challenges, indocyanine green (ICG) fluorescence imaging has been increasingly applied in clinic in recent years (16). ICG is a special fluorescent stain, and it is relatively free of adverse effects. Additionally, ICG allows for excitation by external light in the wavelength range of 750 to 810 nm with near-infrared light emission at a wavelength of approximately 840 nm. The near-infrared fluorescence system is designed to combine fluorescence excitation and fluorescence reception development to achieve fluorescence imaging of ICG (17). The principle of different tissues absorbing ICG at variable absorption rates can be used to effectively distinguish lymphatic tissue from other tissues intraoperatively (18). The introduction of this ICG fluorescence imaging technology in minimally invasive surgery has provided further assurance of accuracy for precision surgery, which presently constitutes an area of intense research interest.

Bibliometric analysis is an efficient interdisciplinary technique involving statistical methods and visualizations for investigating patterns and trends in specific research areas (19,20). Through bibliometrics, we can easily identify the salient information in a given field by performing qualitative and quantitative analyses of the scientific literature on a topic. Moreover, we can characterize the research output and grasp relevant research trends and frontiers within the field (21,22). Bibliometrics has been applied in various fields by numerous researchers to evaluate their respective research areas (23-27).

We used CiteSpace (version 6.1.3, 64-bit) and R Studio (Bibliometrix: R-tool version 3.2.1) in this study to analyze the literature related to the application of ICG in GC and to draw scientific knowledge maps for visualization of this field. This is the first specific scientometric study conducted for knowledge mapping on ICG in GC. We aimed to elucidate the research hot spots and frontiers in this field, provide a reference for ideas of subsequent research, and aid researchers in pursuing new avenues of interest.


Methods

Data source and retrieval strategies

For this study, literature was extracted through the Web of Science (WoS), the most popular and definitive database source for scientific literature, with extensive access to key research findings from around the world. To be more specific, WoS is a multidisciplinary database containing more than 100 subjects and widely used in bibliometric studies to provide essential information on journals and other bibliometric indices.

The refined data retrieval strategy was as follows: (((((TS=(“Stomach Neoplasm”)) OR TS=(“Cancer of Stomach”)) OR TS=(“Stomach Cancers”)) OR TS=(“Gastric Cancer”)) OR TS=(“Gastric Neoplasm”)) AND (((((TS=(“Fluorescence”) OR TS=(“Indocyanine Green”)) OR TS=(“Indocyanine”)) OR TS=(“ICG”)) OR TS=(“Fluorescence Imaging”))). The language of publications in this study was set to English. Among the various document types, only articles and reviews without duplicates were considered. The search period was set from the year 1991 to 2022. To eliminate the effects of frequently updating the database, the literature search and data collection were concluded on November 2, 2022. We excluded 5 articles with little relevance to our study. Finally, 1,385 eligible articles were obtained. The name of the exported file was “download.txt” which was then imported into CiteSpace and R Studio for quantitative evaluation. The procedure of the literature search is shown in Figure 1.

Figure 1 Study flowchart. TS, topic search; ICG, indocyanine green; WoSCC, Web of Science Core Collection.

Analysis tools

This study used CiteSpace version 6.1.3 (64-bit) visualization software to map the scientific knowledge. CiteSpace was developed by the Chinese-American scholar Chaomei Chen as an interactive analytical program based on the fundamental assumption that “scientific knowledge is constantly changing” (28). CiteSpace can structurally and temporally analyze scientific publications to construct collaborative, co-occurrence, and cocitation networks. We additionally used Scimago Graphica, a visualization tool for analyzing and exchanging data, to discern the topographic distribution of publications on ICG in GC.

The acquired data were output to R Studio (Bibliometrix: R-tool version 3.2.1). R Studio is a relatively efficient and integrated version of the R language that is used for data analysis and processing, graphing plotting, and reporting. R Studio was utilized in this study to visualize and analyze the research topic and hotspots accordingly.


Results

General information

We retrieved 1,385 publications in WoS that met the screening criteria, including 1,309 original articles and 76 review articles. Figure 2 shows the results obtained from importing 1,385 documents into Bibliometrix. This figure shows the general information for selected publications. Furthermore, the average age of the literature on the application of ICG in GC was as high as 8.03 years old, and the 32-year time span indicates the long history of the field. Many academics (7,365 authors) contributed to the knowledge in this field, exploring how ICG can be applied more precisely, more efficiently, and more safely in GC. ICG imaging technology has been applied in medical research since the 1950s, from its early use as a dye in cardiac surgery, ophthalmology, neurosurgery, and other fields. In recent decades, its fluorescence properties have been used in sentinel lymph node tracer navigation, tissue blood supply evaluation, lymph node tracing, and other visual surgical operations. The widespread use of ICG has shown positive therapeutic outcomes. The research on the application of ICG in GC began in 1991, showing a slight upward trend overall, with an average citation rate of 27.75% per publication and an average annual growth rate of 15.41% for publications. Overall, the volume of articles associated with the application of ICG in GC has increased year by year, from 1 article published in 1991 to 97 articles published in 2022 (as of November 2, 2022), with an average of more than 70 articles published annually in the last decade (Figure 3).

Figure 2 General information. doc, document; “DE” is a field tag. It is an abbreviation of the frequency distribution of the authors’ keywords.
Figure 3 The overall trend of publications on ICG in gastric cancer applications from 1991 to 2022. ICG, indocyanine green.

The activity of scientific research can be reflected by the growth pattern of the number of scientific publications over time. By analyzing the changes in the volume of literature in a specific discipline and then plotting the corresponding growth curve, we can roughly reveal the characteristics and patterns of scientific development within this discipline, which helps to ascertain the current development status of the discipline and predict its future development trend. Derek de Solla Price is considered to be the father of scientometrics. After conducting a statistical analysis of a large amount of literature, he proposed the law that the volume of scientific and technological documents increases exponentially with time (29). Based on his law, we calculated the logarithm of the cumulative publication volume and then used a linear fit to analyze the correlation between cumulative publication volume and year. We found that the cumulative publication volume grew exponentially after 2001. Therefore, we divided the research time into 2 periods with 2001 being considered the dividing point (P<0.001, Figure 4). The growth in the literature can be broadly described in 4 phases: the initial slow growth phase, the exponential growth phase, the linear growth phase, and the slow growth phase. From the graph, we found that the number of publications grew slowly between 1991 and 2001 (Figure 5), which may indicate that this phase was the initial exploration period of the field and that the research at that time was still in its infancy. The exponential growth in the number of publications from 2001 to 2021 suggests that the use of ICG in GC has been gradually expanding in the latter phase. In the future, we speculate that the frequency of ICG applications in GC will further increase as the sensitivity, specificity, and safety of ICG are further validated.

Figure 4 Trends in number of log (cumulative articles) over time. The red dashed line indicates the result of the a linear fit.
Figure 5 Cumulative number of articles and the annual number of articles over 2 time periods.

Quantitative and collaboration analyses

Country and institution analyses

The 1,385 included papers were published by 1,623 institutions in 58 countries or regions. The top 10 nations in publication number are listed in Table 1. We selected the institutions with the highest number of publications in the top 3 ranked countries. China leads the field in terms of the largest number of publications (645 publications; 24.14 average citations per publication; h-index 55) and also ranks first in the h-index, which is designed to measure the influence and productivity of researchers according to the frequency of their publication citation. The h-index is applied to estimate the academic influence of a country/region, journal, author, or institution (30). Japan is the country with the second most publications after China (311 publications; 34.61 average citations per publication; h-index 53), followed by the United States (151 publications, 40.01 average citations per publication, h-index 43). Apart from the United States, the countries or regions in top 4 for number of publications are from Asia, suggesting significant contributions from researchers in these regions.

Table 1

Top 10 prolific countries or regions and corresponding institutions in the field of ICG in GC

Ranking Countries or regions Corresponding institutions
Country/region Frequency Centrality Institution Frequency Centrality Average citation h-index
1 China 645 0.27 Shanghai Jiao Tong University 51 0.03 24.14 55
Nanjing Medical University 38 0.02
Chinese Academy of Sciences 21 0.03
2 Japan 311 0.07 Kyoto Prefectural University of Medicine 21 0.01 34.61 53
Hamamatsu University School of Medicine 16 0.02
Kanazawa University 11 0.02
3 USA 151 0.22 National Cancer Centre 20 0.07 40.01 43
Memorial Sloan Kettering Cancer Center 7 0
AntiCancer Inc. 6 0.01
4 South Korea 124 0.15 Seoul National University 34 0.05 46.34 33
5 Germany 83 0.41 Technical University of Munich 4 0 56.33 30
6 Italy 41 0.11 The University of Milan 3 0 42.45 16
7 France 23 0.09 University of Strasbourg 2 0 60.22 15
8 Poland 19 0.06 Wielkopolska Cancer Centre 2 0 29.53 9
9 The Netherlands 100 0.02 Leiden University 3 0 136.24 14
10 Brazil 16 0 Federal University of Paraná 10 0 23.82 13

ICG, indocyanine green; GC, gastric cancer.

Centrality is used to indicate the significance of nodes within the network. The centrality level is proportional to the importance of the nodes. The top 3 countries or regions in centrality in this study were Germany (0.41), China (0.27), and the United States (0.22). Although Germany ranked only fifth in terms of the publication quantity, it had the highest centrality, which indicates that Germany plays an important bridging role in the close cooperation with other countries or regions in this field. We used Scimago Graphica to analyze the topographic distribution of collaboration between countries or regions associated with the use of ICG in GC (Figure 6). Based on this analysis, we drew graphs for better visualization. In Figure 6, the circle size is proportional to the volume of publications, and the boldness of the lines indicates the density of collaboration among countries or regions; the redder a country’s node is, the greater the total number of research papers that the country has published through collaboration with other countries. We found that China had the closest cooperative relationship with the United States. In addition, China had a wide range of collaborations with other countries or regions, including Germany, South Korea, and Japan, among others. In contrast, some developed countries, such as those in Europe, showed less collaboration with other countries.

Figure 6 Geographical distribution of collaboration between countries or regions in the field of ICG in GC. ICG, indocyanine green; GC, gastric cancer.

Research institutions are oriented research forces, and the research perspectives of important research institutions often influence the academic circle in this field. In Table 1, the top 3 institutions in terms of the number of publications were Shanghai Jiao Tong University (51 publications), Nanjing Medical University (38 publications), and Seoul National University (34 publications). In the modern era, a variety of therapeutic cancer strategies such as photothermal therapy (PTT) have proven essential in overcoming the primary barrier of GC variability and complexity. A study from Shanghai Jiao Tong University reported on the controllable delivery and release of distinctly targeted ICG and the outstanding tumor inhibiting efficacy of PTT, creating a promising avenue for effective cancer treatment (31). Nanjing Medical University’s 2021 study retrospectively collected patients with a diagnosis of GC in consecutive years who received laparoscopic radical GC surgery. The study then matched patient samples on a 1:1 basis in terms of propensity scores and finally compared the results of the 2 groups. The results demonstrated that ICG-guided laparoscopic radical gastrectomy is reliable and efficacious (32).

In terms of centrality, the National Cancer Centre (0.07) had the highest score among institutions, followed by Seoul National University (0.05), Shanghai Jiao Tong University (0.03), and the Chinese Academy of Sciences (0.03). A recent study by Seoul National University found that ICG fluorescence imaging with tissue marking dyes is helpful for visualizing the perigastric lymphatic network in advanced gastric cancer (AGC) and for tracking the precise position of ICG-stained lymph nodes. Despite this, ICG imaging is not generally preferred for selective lymph node dissection in AGC due to confined perigastric lymph node staining (33).

Furthermore, we mapped research institutional collaboration using CiteSpace. The institutional collaboration network knowledge graph consists of 158 nodes and 121 links. In Figure 7, the node size indicates the quantity of publications within the institution, and the node color and thickness indicate the quantity of publications at various time frames. The high-yield institutions are concentrated in Asian countries, especially China. This indicates that Asian-located institutions are an important research force in this field. Many Chinese institutions (Shanghai Jiao Tong University, Chinese Academy of Sciences, Nanjing Medical University) have established close ties with one another, indicating that China has a relatively advanced status of study within this area and has an array of research institutions with core competencies.

Figure 7 Knowledge map and institutional collaboration network of ICG in GC. ICG, indocyanine green; GC, gastric cancer.

Author and coauthor analyses

Reviewing the literature produced by highly influential authors in a field can provide a quicker means of more comprehensively grasping the classical theory in this field. In our study, we found that a total of 7,365 authors contributed 1,385 articles to the field of ICG in GC. Table 2 lists the leading authors by volume of publications.

Table 2

Top 10 most productive authors and top 10 most cocited authors in ICG research

Ranking Most productive authors Most cocited authors
Author Count h-index Author Count h-index
1 Li Y 54 22 Bang YJ 185 87
2 Wang Y 48 24 Hofmann M 112 2
3 Liu Y 43 22 Jemal A 89 128
4 Zhang Y 43 31 Miyashiro I 79 41
5 Wang J 34 5 Ferlay J 70 4
6 Zhang X 34 16 Ruschoff J 66 48
7 Kim H 32 14 Kitagawa Y 64 62
8 Li Z 30 8 Tajima Y 63 18
9 Chen J 25 25 Gravalos C 62 11
10 Zhang J 25 29 Bray F 62 108

ICG, indocyanine green.

Li Y had the highest volume of publications (54 papers; h-index 22), followed by Wang Y (48 papers; h-index 24). Liu Y, Zhang Y, and Wang J were next in the highest number of publications, respectively. Zhang Y had the highest h-index among those ranked top 10 in the number of publications. He is dedicated to the research of anticancer drugs, but we found that his papers have not been included in WoS in recent years. His latest study described a color-coded imaging model. According to this model, the quantification of neointimal length can be achieved by implanting Gelfoam into nestin-driven green fluorescent protein (ND-GFP) nude mice. Using color-coded imaging, he also identified Salmonella typhimurium A1-R as potentially applicable in antiosteosarcoma angiogenesis-targeted therapy (34). Wang Y was not only the second most published author in this field, but his paper titled “Differential expression of microRNA species in human gastric cancer versus non-tumorous tissues” was the top ranked article among the top 10 cited articles (Table 3) (35). This paper constitutes one of the earliest reported associations of microRNAs (miRNAs) with GC. This novel finding could indicate a possible role of miRNA in the diagnosis of GC. The third most cited article titled “The clinical use of indocyanine green as a near-infrared fluorescent contrast agent for image-guided oncologic surgery” analyzed the advantages and limitations of the application of ICG in near-infrared fluorescence cancer-related surgical treatment (36).

Table 3

Top 10 most cited publications

Ranking Article title Cited frequency
Average annual citation frequency Count
1 Assessment of a HER2 scoring system for gastric cancer: results from a validation study 55.73 836
2 Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-esophageal junction cancer (ToGA): a phase 3, open-label, randomized controlled trial 56.92 740
3 The clinical use of indocyanine green as a near-infrared fluorescent contrast agent for image-guided oncologic surgery 46.83 562
4 Circular RNA cSMARCA5 inhibits growth and metastasis in hepatocellular carcinoma 85.8 429
5 Lapatinib plus paclitaxel versus paclitaxel alone in the second-line treatment of HER2-amplified advanced gastric cancer in Asian populations: TyTAN–a randomized, phase III study 46.44 418
6 Differential expression of microRNA species in human gastric cancer versus non-tumorous tissues 29.43 412
7 Circular RNA_LARP4 inhibits cell proliferation and invasion of gastric cancer by sponging miR-424-5p and regulating LATS1 64.17 385
8 HER2 testing in gastric cancer: a practical approach 34.73 382
9 HER2 diagnostics in gastric cancer-guideline validation and development of standardized immunohistochemical testing 27.38 356
10 MET amplification identifies a small and aggressive subgroup of esophagogastric adenocarcinoma with evidence of responsiveness to crizotinib 29.58 355

HER2, human epidermal growth factor receptor 2; ToGA, Trastuzumab for Gastric Cancer; MET, mesenchymal to epithelial transition.

A knowledge map of authors’ collaboration, consisting of 852 nodes and 1,622 links, is shown in Figure 8. The node size indicates the quantity of authors’ publications, and the lines and their thickness indicate the relative degree of collaboration between authors. We found that the authors of relevant ICG studies were mainly located in Asia. Chinese authors have contributed greatly to this area and have established extensive contacts with other authors in China. In Figure 8, a purple circle indicates an author centrality greater than 0.1. From the figure, we can discern that there are no authors with high centrality in China, indicating that China’s research results are relatively independent, and thus Chinese research in this field could be strengthened via greater cooperation with other countries.

Figure 8 Knowledge map of authors’ collaboration network related to ICG in GC. ICG, indocyanine green; GC, gastric cancer.

In addition, the cocitation analysis of authors allows for the identification of key authors in the in a given field. In general, commonly cited authors are considered to be more influential than less frequently cited authors, and cocited authors are likely to focus on related research areas. In this study, Bang YJ, from the Seoul National University College of Medicine, was found to be the most commonly cocited author, with a total citation frequency of 185. Over the past few years, his research has focused on the use of pembrolizumab to treat GC. Human epidermal growth factor receptor 2 (HER2) overexpression/expansion correlates to the progression of diverse solid tumor patterns. Based on the relationship between HER2 and GC, some researchers have inspected the status of GC by detecting the status of HER2. The second most cited author Hofmann M used fluorescence in situ hybridization (FISH) to determine the HER2 status in formalin-fixed, paraffin-embedded GC samples. Combined with this test technique, a GC HER2 scoring system was established to identify patients with advanced metastatic GC eligible for trastuzumab trials (37). Based on the above 2 authors’ studies, we can speculate that fluorescence assay is a capable method for detecting the therapeutic effect of anticancer drugs.

Higher-impact journal analysis

A total of 1,385 papers concerning the application of ICG to GC were published in 512 journals. The top 10 journals with the most publications were visualized using the R-tool bibliometrix (Figure 9). Table 4 provides the essential summary profiles of the top 10 most prolific journals and cocited journals, respectively. Among leading journals with the highest number of publications, World Journal of Gastroenterology [43 publications; 2021 impact factor 5.374 (Q2)] ranked first, followed by Gastric Cancer and Oncology Letters (31 and 26 publications, respectively). The annual publication volume of these journals in the last decade has been concentrated around 2–4 articles. In 2018, 8 related articles were published by Oncology Letters, which is the highest volume of annual publications among these journals over the past 3 decades (Figure 10). We found that International Journal of Oncology was the first journal to publish in this field, but as of 2022, it only ranked fourth in terms of the number of articles published. World Journal of Gastroenterology began to include ICG-related articles in 1991 and have since published an ever-growing number of relevant papers. This journal ranked first among the top 5 journals for the volume of papers published. Gastric Cancer started late with the inclusion of ICG-related articles in 2007 but has since then moved to second place in terms of the volume of relevant articles published (Figure 11).

Figure 9 Top 10 journals in terms of the number of publications.

Table 4

Top 10 most prolific journals and cocited journals that published articles on ICG in GC

Ranking Prolific journal Cocited journal
Journal name Output IF JCR Journal name Citation IF JCR
1 World Journal of Gastroenterology 43 5.374 Q2 Cancer Res 576 13.312 Q1
2 Gastric Cancer 31 7.701 Q1 Int J Cancer 440 7.316 Q1
3 Oncology Letters 26 3.111 Q3 J Clin Oncol 413 50.717 Q1
4 International Journal of Oncology 22 5.884 Q2 Clin Cancer Res 412 13.801 Q1
5 Oncology Reports 19 4.136 Q2 P Natl Acad Sci USA 395 12.779 Q1
6 Surgical Endoscopy and Other Interventional Techniques Interventional Techniques 18 3.453 Q2 Brit J Cancer 382 9.075 Q1
7 Annals of Surgical Oncology 17 4.339 Q1 Lancet 363 202.731 Q1
8 Anticancer Research 17 2.435 Q4 Nature 356 69.504 Q1
9 PLOS One 17 3.752 Q2 Science 352 63.714 Q1
10 Scientific Reports Cancer Institute 17 4.996 Q2 Gastric Cancer 330 7.701 Q1

ICG, indocyanine green; GC, gastric cancer; IF, impact factor; JCR, Journal Citation Reports.

Figure 10 The trends of the top 5 journals in terms of annual publication.
Figure 11 The trends of the top 5 journals in terms of total number of publications.

The journal impact factor is an important indicator of the value of articles (38). The impact factor in the majority of journals in this study was below 5, which indicates that the level of research in this field is not very high. Researchers need to intensify efforts to elevate the research level in this field and improve the quality of articles. Cocitation frequency determines the journal’s impact and indicates if it has had a significant influence over a specific area of research. Our results indicated that Cancer Research ranked first among the cocited journals, indicating its absolute impact on the application of ICG in GC. Almost any cocited journal was found to be closely associated with cancer research. Moreover, all cocited journals were Q1 (e.g., Nature and Science), which indicates that the quality of cocited articles in the field is extremely high and produced from journals with high impact.

References with a citation burst

A citation burst is a surge in citations of certain papers over a short period of time. Research trends in a given field can be predicted through analysis of reference citation bursts (39). In Figure 12, the red lines indicate the citation outbreak duration, denoting the development of popular topics while the blue lines represent the time intervals. The strength of the burst is proportional to the impact of the publication. In 2010, Bang YJ published the first reference to have the maximum burst intensity in Lancet. The samples for this study included only patients with tumors showing HER2 protein overexpression according to immunohistochemistry and patients with tumors showing HER2 protein-related gene amplification according to FISH. With the help of these sample of patients, he revealed that trastuzumab coupled with chemotherapy may be regarded as an emerging criterion for screening HER2-positive patients with late-stage GC (40).

Figure 12 Top 25 references in terms of strongest citation bursts.

Among the top 25 articles with the highest citation bursts, 6 had citation bursts ending in 2022. This is consistent with the recent emergence of ICG research. Lan et al. developed ICG combined with near-infrared imaging as a prospective approach for locating lymph in the robotic gastrectomy of GC (41). Huh et al.’s study demonstrates that the use of near infrared imaging with ICG-enhanced fluorescence is a feasible and effective method for evaluating blood vessel perfusion in the surgical anastomosis of GC (42). Kwon et al.’s findings in 2019 suggest that ICG may help to identify and visualize each lymph node draining from the primary lesion intraoperatively to perform thorough lymph node dissection (43). Rüschoff et al.’s paper titled “HER2 testing in gastric cancer: a practical approach” had the longest citation burst among the top 25 references. In this paper, the authors used immunohistochemistry as an initial testing method. Furthermore, given the predictive value of HER2 protein levels related to response in trastuzumab treatment studies for GC, FISH or silver in situ hybridization was used to reassay immunohistochemical 2+ samples (44).

Research topic and hotspots analysis

Keyword analysis

Keywords are a distillation and abstract of the article’s research theme and content, and they are a manifestation of the content of the article. Identification of research hotspots in a given field can be achieved through keyword co-occurrence analysis. Table 5 shows that in keyword frequency ranking, “gastric cancer” appeared 778 times, ranking first, followed by “expression” (n=255), “carcinoma” (n=195), “breast cancer” (n=149), and “indocyanine green” (n=100), indicating that the use of ICG in GC, particularly in detecting the expression of genes or proteins, has been a popular research topic worldwide. The top 3 keywords for centrality were “gastric cancer” (centrality 0.17), “expression” (centrality 0.16), and “carcinoma” (centrality 0.12). In terms of the chronological order of the first occurrence of keywords, “indocyanine green” is relatively recently introduced. This indicates that the use of ICG in GC is relatively cutting edge.

Table 5

Top 20 keywords in ICG in GC research

Ranking Keyword Centrality Count Year
1 Gastric cancer 0.17 778 1991
2 Expression 0.16 255 1991
3 Carcinoma 0.12 195 1992
4 Breast cancer 0.1 149 1995
5 Indocyanine green 0.02 100 2006
6 In situ hybridization 0.06 97 1998
7 Cancer 0.11 95 1997
8 Gene amplification 0.03 83 1998
9 Growth 0.04 79 2000
10 Colorectal cancer 0.04 77 1996
11 Apoptosis 0.07 73 2001
12 Cell 0.05 69 1993
13 Therapy 0.05 66 2002
14 Survival 0.04 65 1997
15 Identification 0.11 63 1991
16 Amplification 0.07 62 1996
17 Gene 0.04 61 1999
18 Metastasis 0.02 61 2007
19 Adenocarcinoma 0.06 60 1996
20 Overexpression 0.02 56 1997

ICG, indocyanine green; GC, gastric cancer.

A keyword burst refers to keywords whose frequency surges within a short period. Through the analysis of emergent keywords, we could determine the cutting edge of research and further ascertain the development trend of future research. Figure 13 lists the top 25 outbreak keywords, with the shortest duration being 1 year and the longest being 15 years. “In-situ hybridization” (burst strength 11.99) had the highest burst strength and the longest duration, indicating that it was a hot topic before 2013, receiving sustained attention. The second ranked keyword in terms of burst strength was “proliferation” (burst strength 10.53), followed by “trastuzumab” (burst strength 9.16). “Indocyanine green” was the fifth ranked in burst strength. Although it first appeared in 1991, it began to be studied in 2020 and continued to be a hot topic in 2022. Over the past 3 years, researchers have focused mainly on “migration” (burst strength 6.03; duration 2019–2022), “indocyanine green” (burst strength 8.66; duration 2020–2022), and “lymph node dissection” (burst strength 5.84; duration 2020–2022).

Figure 13 Top 25 keywords with the strongest citation bursts.

Moreover, R Studio was used to draw a graph of the distribution of 30 high-frequency keywords against time, as seen in Figure 14, in which every cell indicates the frequency of the keyword occurring within a year. These occurrence frequencies (0–1) were normalized to form the corresponding values. The lowest value in the black cell indicates the least frequent occurrence of the keyword in the year. The yellow cells have the largest value, corresponding to the most frequent occurrence of the keyword in the year. The frequency of “gastric cancer” and “apoptosis” is high from 2012 to 2022 (as of November 2022), while the occurrence frequency of “HER2” gradually increased from 2012 to 2015 and showed a decreasing trend from 2016 to 2022. Over the past 5 years, the frequency of “FISH” has decreased while the frequency of “ICG” has gradually increased.

Figure 14 Distribution of the 30 most high-frequency keywords over time. HER2, human epidermal growth factor receptor 2.

Finally, the R-tool bibliometrix was used to process 250 keywords (Figure 15), in which the minimal clustering frequency was 5, and each clustering had a count of 5 labels. In Figure 15, the x-axis denotes centrality, which shows the significance of the topic while the y-axis denotes density, which shows the development degree of research on the topic. The upper right quadrant (motion theme) has high-intensity and high-centrality features, indicating that it could be a well-established and significant subject within the ICG research domain. In the motor themes, the main domains of research are “gastric cancer”, “expression”, “carcinoma”, “breast cancer”, and “cancer”. Motor themes are considered to be themes that support the development and strengthening of areas of knowledge because of their centrality and density. The upper left quadrant (niche themes) represents a subject with good internal development. The cluster includes “apoptosis”, “proliferation”, “in-vitro”, “activation”, and “pathway”. Clusters from the third quadrant (new or falling topics) were marked as less central and less dense; that is, less advanced, gradually emerging, as well as marginally significant, with “surgery”, “biopsy”, “lymphadenectomy”, “dissection” and “gastrectomy” as major themes. The thematic keywords belonging to basic themes with weak intrinsic development are “metastasis”, “ICG”, “diagnosis”, “fluorescence” and “in vivo”. They cover general themes that span different research areas in the field.

Figure 15 The keywords thematic map generated with the R-tool bibliometrix.

Three-field plot for top authors, keywords, and countries

We used a three-field diagram to plot the relationship between the top 10 authors, keywords, and countries in terms of research intensity, as shown in Figure 16. The height of the rectangle in the three-field diagram is based on the rate or value of the sum of the relationships generated between the components plotted in the three-field diagram. The closer the relationships between the plotted components are, the taller the rectangle appears. We found that the authors’ studies, mainly in China, Japan, and Korea, focused on keywords such as “gastric cancer”, “HER2”, “apoptosis”, “immunohistochemistry”, “FISH”, and “ICG”, among others, The relevant articles from China covered almost all keywords, while those covered by Europe and the United States were not comprehensive in terms of quantity, indicating that China dominates the field in this regard.

Figure 16 Relations between authors (left), keywords (middle), and countries (right) in ICG in GC research. ICG, indocyanine green; GC, gastric cancer.

Discussion

General information

This study systematically searched the WoS database for papers related to ICG in GC published between 1991 and 2022. Ultimately, we retrieved 1,385 publications in WoS that met the eligibility criteria. As can be observed from Figure 3, the average yearly increase in publications related to ICG in GC was 15.41%, increasing from 1 publication in 1991 to 107 publications in 2021. The active level scientific research can be reflected by the growth pattern of the number of scientific publications over time. Based on the Price law of exponential growth of scientific and technical literature over time, we found that cumulative publications grew exponentially after 2001. The research time was divided into 2 periods by with 2001 being used as the cutoff point (P value <0.001; Figures 4,5), including a slow growth phase [1991–2001] and an exponential growth phase [2001–2021]. This may be due to the first use of sentinel lymph node biopsies with ICG in GC surgery by Hiratsuka et al. in 2001 (45). The procedure had excellent reliability and the sentinel lymph node status was able to predict lymph node status quite accurately. In the same year, ICG-sulfo-OSu-labeled antihuman carcinoembryonic antigen antibody and infrared fluorescence endoscopy emerged as a technology for detecting human GC in resected specimens in vitro, which attracted considerable interest in the application of ICG to GC (46). These 2 successful initiatives in 2001 heralded an era of the practical use of ICG in GC. Hence, the number of articles published in this field has grown at an impressive rate since 2001, suggesting that this field is attracting extensive attention and that the clinical application of ICG in GC is gradually maturing. The detection accuracy and therapeutic efficacy of ICG have also been further confirmed in an increasing number of clinical applications, and the scope and means of ICG application have been further developed and expanded. In summary, research in this area will continue to be a research hot spot.

To understand the spatial distribution of research contributions in this area, we analyzed and visualized the distribution across states and institutions, the outcomes of which are presented in Table 1. According to the spatial distribution of publication, researchers in different regions can adjust the strategic layout of their research collaboration, thus making their future collaboration efficient and their information access up-to-date, maintaining and improving their contribution position within the area. Regarding the volume of published articles, China ranked first in this area with 628 publications, followed by Japan and the United States. The h-index is a metric for determining the influence and productivity of a researcher’s publications according to the frequency of the publication citation, and it is widely applied in evaluating the scholarly influence of a country/region, journal, author, or institution (30). The examination of the h-index distribution in this study produced results that basically agree with the national distribution, with China’s h-index (h-index =55) ranking first, followed by Japan (h-index =53) and the United States (h-index =43). Generally, East Asia made a greater contribution in this field both in terms of quantity and quality of publications. This may be related to regional differences in the distribution of GC incidence, as East Asia was one the regions with the highest incidences of GC in 2020. In addition, aside from the United States, most of the top 5 countries/regions in terms of number of publications were in Asia, reflecting the dominance of this region in this domain. Centrality can indicate the key nodes in a network, with the level of centrality scaling with the significance of the node (47). The top 3 countries or regions in terms of centrality were Germany (0.41), China (0.27), and the United States (0.22). Although Germany ranked only fifth in publication volume, it had the highest centrality, indicating that Germany has a major cohering function in this area via a close cooperation with other countries or regions, but there remains potential for growth regarding the efficiency and quality of the products of collaboration.

Regarding institutions, Table 1 shows that the top 3 institutions in terms of publication volume were Shanghai Jiao Tong University (51 publications), Nanjing Medical University (38 publications), and Seoul National University (34 publications). The top institutions in terms of output were mainly located in Asian countries, especially China. This indicates that Asian institutions are an influential region in this area of research (Figure 7). Moreover, many institutions in China are actively collaborating in research in this area and have developed close connections. On the one hand, this internal collaboration suggests that China has developed research institutions with core competencies, which can complement one another and coordinate well within the country. On the other hand, it may also limit China’s cooperation in this field with the rest of the world, leaving China central less than its high number of publications might indicate.

Through access to journal source analysis, researchers can not only easily and efficiently find the right journal for their research but can also visualize the more influential journals in the field and thus have a better chance of obtaining cutting-edge information. Analysis of journals and cocited journals revealed that World Journal of Gastroenterology (n=43) was the journal with the highest number of ICG-related publications, followed by Gastric Cancer (n=31) and Oncology Letters (n=26), suggesting a special interest and significant contribution of these journals to articles on innovative therapies for GC. Regarding the quality of research, only 3 of the top 10 journals showed impact factors above 5 (World Journal of Gastroenterology, Gastric Cancer, and International Journal of Oncology), which suggests a need for an improvement in output impact. Accordingly, the number of articles in this field included in some high-impact journals was low, indicating that the research on ICG application to GC has not been fully appreciated and may become a new hot spot to be included in high-impact journals in the future. Meanwhile, Cancer Research (576 citations) ranked first among the cocited journals. All cocited journals including Nature and Science have Q1 Journal Citation Report (JCR) rankings. These journals are the core influencers in their respective academic fields, which reflects the importance of the application of ICG in GC in the related fields in which these core journals dominate. It also shows that journals that have made major core contributions to the field and have high impact are generally of higher quality. The number of articles in journals need to be further balanced with the quality to increase the impact of the journal. This has also inspired and motivated researchers to expand and develop innovative ways to apply ICG in GC. In general, the literature of highly influential authors in the field can help us grasp the classical theory of the field more efficiently and comprehensively. The h-index is one of the indicators to assess the productivity and quality of a given author’s output (48). An examination of author contributions and cocited authors (Table 2) revealed that Li Y contributed 54 articles with an h-index of 32 and was the most published author in the field. Additionally, Zhang Y, who has been dedicated to research into anticancer drugs, had the highest h-index (h-index =31) and was among the 10 most prolific authors. When cocited authors were taken into account, Bang YJ from Seoul National University School of Medicine was the most cited author with 185 cocitations, indicating that this author has a central role in pioneering research in the field. A knowledge map of author collaboration, consisting of 852 nodes and 1,622 links, is presented in Figure 8. We found that the authors of relevant ICG studies were mainly located in Asia. It is notable that Chinese researchers have made significant contributions in this area and have established extensive links with other researchers in China. However, cooperation with other countries should be strengthened to expand the country’s influence in the world and to further increase the output of scientific research in this field.

Among the top 10 most cited papers, that of Schaafsma et al. analyzed the advantages and limitations of ICG in near-infrared fluorescence cancer-related surgery (36). The results showed that despite nontargeting and nonconjugation characteristics, ICG lays the basis for an extensive application of near-infrared fluorescence-guided surgery. Among 25 papers with the strongest citation bursts, 6 had a burst that ended in 2022. It is encouraging to see that research on the application of ICG in GC has led to some breakthroughs. For instance, Lan et al. found near-infrared fluorescence imaging of ICG to be promising approach for lymph mapping during robotic gastrectomy of GC (41). Similarly, the Kwon et al.’s findings in 2019 suggested that ICG may be useful for the intraoperative identification and visualization of each draining lymph node of primary lesions, which aid in performing complete and thorough lymph node dissection (43). Moreover, Huh et al.’s study showed that near-infrared imaging with an ICG-enhanced fluorescence technique could be a viable and efficacious means of assessing the vascular perfusion of surgical anastomoses in GC (42). The above studies have served as a crucial basis in developing this field and providing directions and support for the application of ICG in GC, simultaneously allowing clearer insight into the progress of ICG applications in GC.

Research hot spots and frontiers

As a distillation and overview of study themes and article contents, keywords reflect the main theme and research direction of a paper. Through a co-occurrence analysis of keywords in a field, researchers can extract the most research topics in a given field based on their frequency of occurrence. Table 5 summarizes the results of the keyword analysis of our study, with “gastric cancer” appearing 788 times, ranking first, followed by “expression” (n=255), “carcinoma” (n=195), “breast cancer” (n=149), and “indocyanine green” (n=100). These keywords appear more frequently in papers discussing ICG applications in GC, and to some extent represent the hot spots of research in this area. The keyword “indocyanine green” was first mentioned in 2006 and ranked among the top 10 only after “metastasis” in the keyword frequency ranking in 2006. The recent appearance of ICG and the high frequency of its first appearance indicate that the application of ICG in GC is relatively cutting edge and has high exploration value. ICG in GC is currently used for precision imaging and accurate identification in the surgical treatment of patients with GC, and its imaging properties can also be used to explore the potential impact of gene and protein expression profiles on cancer development. “Breast cancer” is among the top 5 keywords in terms of frequency of occurrence, indicating that the application scope and prospect of ICG are relatively broad, the imaging detection technology of ICG can be widely applied to similar cancer diseases, and its research significance and value are high.

A keyword burst is where the keyword frequency spikes over a given duration. Analysis of the keywords that appear at each stage allows for the identification of how the frontiers of research in the field are advancing and further reveals trends in future research. The evolution of the keywords burst related to ICG is shown in Figure 13, with “in-situ hybridization” (burst strength 11.99) having the highest burst strength and the longest duration. Notably, “indocyanine green” ranked fifth according to burst strength, with bursts initiating in 2020 and persisting until now. This indicates that the research direction in ICG is attracting considerable recently and has good prospects. More importantly, research in the past 3 years has focused on “migration” (burst strength 6.03; duration 2019–2022), “indocyanine green” (burst strength 8.66; period: 2020–2022), and “lymph node clearance” (burst strength 5.84; duration 2020–2022). This suggests that these research topics may be research trends in the application of ICG in GC, with application modalities such as tumor migration monitoring and imaging of lymph node clearance being particularly prominent in this field. Additionally, a distribution diagram for 30 keywords with high frequency was created using R Studio (Figure 14). The results revealed that the frequency of “gastric cancer” and “apoptosis” increased from 2012 to 2022 (as of November 2022) and that the frequency of ICG has gradually increased over the past 5 years.

Based on what has been stated above, the clinical application of ICG in GC is not yet mature and is still in the developmental stage. Currently, ICG is used as a tracer and imaging tool during GC surgery, with its fluoroimaging being leveraged for microinvasive and precision surgery. ICG technology was used first in Asian countries to detect anterior lymph nodes in patients with EGC during GC surgery (49). The widespread use of near-infrared and ICG in Asian countries such as China has resulted in encouraging results in the prognosis of patients of GC, but the prognosis of GC in Western populations is still poor (1,50). This discrepancy can be directly attributed to the outstanding contributions made by relevant institutions and researchers in Asian countries such as China, Japan, and South Korea in applying ICG to GC. In a study published in JAMA Surgery, Huang et al. explored the impact of ICG technology on the safety and efficacy of lymph node dissection in patients with cancer (51). The findings of this study demonstrated that ICG markedly increased lymph node clearance in patients undergoing radical surgery for D2 GC and reduced the lymph node disqualification rate but did not increase the rate of postoperative complications; this study thus provides a valuable evidence-based medical basis for the application of ICG’s tracer technique in GC surgery and supports its routine use in GC treatment. The success of gastrectomy following coronary artery bypass grafting in a patient with GC reported in 2023 also evinces the role and feasibility of ICG fluorescence technology in surgery. This procedure used ICG fluorescence technology to navigate the sentinel lymph nodes and to image and identify the blood vessels during the operation to (52), overall enhancing visualization during surgery and increasing the success rate of surgery. Additionally, a recent study published in Cancers evaluated the effectiveness of ICG diffusion which can be used to determine the resection margins for gastrectomy surgery. This study found that ICG diffusion extent combined with near-infrared imaging can be used as a simple and easy method to define the incisional margin in gastrectomy (53). It can be seen that given the convenience and effectiveness of ICG in the application of GC treatment, ICG has gradually become a powerful tool in the treatment of GC.

However, further confirmation of the application of near-infrared and ICG technology, the gain effect, and the safety of the procedure is needed. The actual clinical value of ICG remains a matter of debate due to the current lack of confirmation from clinical studies. Additional high-quality randomized controlled tests to substantiate such benefits are urgently required (54). Although several studies have shown a markedly larger average count of lymph nodes detected for an ICG group than for a non-ICG group (55), some scholars reported the opposite result. Therefore, more clinical trial results may be needed to reduce the impact of errors caused by surgical personnel in surgical and experimental trials and to confirm the effect of ICG imaging. In addition, since imaging technology has not yet been combined with machine recognition, ICG imaging may only provide surgical guidance to the surgical staff and not a surgical machine. Lan et al. found there to be an absence of marked variation of lymph nodes removed in patients treated with or without the near-infrared and ICG technique for robotic gastrectomy (41). Fortunately, findings from the iGreenGO study, published in Frontiers in Oncology, clarify how near-infrared and ICG technology works to assist surgeons in performing lymph node dissection in AGC (56). Furthermore, a recently published study in Cancers systematically reviewed modern uses of ICG-enhanced fluorescence imaging (ICG-FI) and evaluated the possible approaches that could improve ICG-FI. These studies provide the basis and guidance for the application of ICG in GC surgery, promote the maturation of ICG imaging tracer technology from theory to practice, and offer solutions to adapting ICG to surgery. The clinical translation of ICG for GC application in terms of basic theory may also become a new research hot spot, which is likely to provide high-value, groundbreaking results.

Although ICG is the only near-infrared imaging agent approved by Food and Drug Administration (FDA) for clinical use, it also has several intrinsic drawbacks that limit its development (57). Stable agents with relatively longer circulation times, along with good biocompatibility and specific targeting to tumors, are prerequisites for satisfactory fluorescence imaging. Unfortunately, the instability and self-aggregation of ICG in solution lead to fluorescence quenching and a short half-time in vivo. In addition, ICG is defective in its tumor-targeting ability (58). These drawbacks led to the early termination of the JCOG0302 study due to an unacceptable false-negative rate (59). Researchers have attempted to introduce a large number of carriers to encapsulate ICG to protect ICG from nonspecific binding of plasma proteins and enhance its stability and tumor targeting. Fortunately, an arginylglycylaspartic acid (RGD)-modified distearyl acylphosphatidyl ethanolamine-polyethylene glycol micelle (DSPE-PEG-RGD) encapsulating ICG targeting GC was designed and synthesized with significant biocompatibility and improved intratumor targeting accumulation (60). Nevertheless, improving tumor penetration and targeting ability remains a challenge.

Our bibliometric study systematically analyzed the general information, hot spots, cutting-edge research in the research of ICG applications in GC from a visual perspective. The findings offer more objective and reliable data and serve as a support reference for clinicians and scholars in understanding the basic situation of the field and selecting the appropriate research direction. ICG plays an important role in GC by virtue its imaging tracer capabilities. Specifically, ICG can be used for imaging guidance in minimally invasive procedures in GC and to assess organ-related issues, such as hematologic conditions. According to our analysis, overall, the application of ICG in GC is a current research hot spot, and the studies conducted in this field demonstrate that ICG offers many benefits in the surgical treatment of GC (61). Nonetheless, more studies are needed to support this trend, both in terms of standardizing the applied techniques and definitively demonstrating the efficacy of ICG application itself; therefore, the core ICG techniques should be validated, promoted, and further developed in the future.

Limitations

Although this bibliometric analysis has generated substantial and valuable information to enable researchers to more quickly grasp the frontiers in this field, it inevitably has some limitations. Our study investigated data exclusively from the WoS and focused on English-language papers, which might have restricted the literature included in the analysis. Moreover, the uneven quality of the collected literature data may hamper the credibility of the knowledge mapping. Finally, it is likely that the recent publications, despite their high quality, might not garner commensurate attention due to their low citation rates. Nonetheless, visual analysis of reference-based data can undoubtedly aid researchers in grasping the emerging research trends and hot spots of ICG in GC.


Conclusions

This paper presents a bibliometric analysis of articles focusing on ICG in GC published from 1991 to 2022. Therapy for AGC is already in the stage of individualized and precise treatment, and ICG has research and application potential in GC therapy. Research in this field has been increasing continuously and exponentially, with the leading countries being China, Japan, and the United States. The current study trends and cutting-edge research in this area mainly focus on the application of ICG in EGC and lymphatic drainage guidance for progressive GC, which may also constitute the future research trends in this area. The introduction of ICG in the minimally invasive gastric resection or function-preserving gastrectomy in accordance with the concept of precision surgery can effectively improve patient prognosis and reduce morbidity. In summary, ICG has great potential in the fluorescence imaging of GC, and the technique has made significant progress in recent years, providing a promising means for detecting and accurately resecting GC. Improving tumor penetration and targeting and conducting large clinical trials to validate the utility of ICG are urgently required and should be realized to ultimately revolutionize clinical treatment modalities.


Acknowledgments

We would like to express our appreciation to Prof. CM Chen, founder of CiteSpace, which is free to use. We are indebted to the WoS database, which provided us with unrestricted online access.

Funding: This study was supported by the National Natural Science Foundation of China (No. 81960503), the Nature Foundation Project of Jiangxi Province (No. 20224ACB206029), the Leading Talents Program of Jiangxi (No. 20213BCJL22050), and the Talent 555 Project of Jiangxi Province (No. 700238003).


Footnote

Conflicts of Interest: All authors have completed the ICMJE uniform disclosure form (available at https://qims.amegroups.com/article/view/10.21037/qims-23-391/coif). The authors have no conflicts of interest to declare.

Ethical Statement: The authors are accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved. Due to the literature review design of the present study, neither ethics approval nor informed consent was applicable.

Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0/.


References

  1. Sitarz R, Skierucha M, Mielko J, Offerhaus GJA, Maciejewski R, Polkowski WP. Gastric cancer: epidemiology, prevention, classification, and treatment. Cancer Manag Res 2018;10:239-48. [Crossref] [PubMed]
  2. Ma J, Shen H, Kapesa L, Zeng S. Lauren classification and individualized chemotherapy in gastric cancer. Oncol Lett 2016;11:2959-64. [Crossref] [PubMed]
  3. Torre LA, Siegel RL, Ward EM, Jemal A. Global Cancer Incidence and Mortality Rates and Trends--An Update. Cancer Epidemiol Biomarkers Prev 2016;25:16-27. [Crossref] [PubMed]
  4. The global, regional, and national burden of stomach cancer in 195 countries, 1990-2017: a systematic analysis for the Global Burden of Disease study 2017. Lancet Gastroenterol Hepatol 2020;5:42-54. [Crossref] [PubMed]
  5. Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin 2021;71:209-49. [Crossref] [PubMed]
  6. Zheng R, Zhang S, Zeng H, Wang S, Sun K, Chen R, Li L, Wei W, He J. Cancer incidence and mortality in China, 2016. Journal of the National Cancer Center 2022;2:1-9.
  7. Bergquist JR, Leiting JL, Habermann EB, Cleary SP, Kendrick ML, Smoot RL, Nagorney DM, Truty MJ, Grotz TE. Early-onset gastric cancer is a distinct disease with worrisome trends and oncogenic features. Surgery 2019;166:547-55. [Crossref] [PubMed]
  8. Arnold M, Park JY, Camargo MC, Lunet N, Forman D, Soerjomataram I. Is gastric cancer becoming a rare disease? A global assessment of predicted incidence trends to 2035. Gut 2020;69:823-9. [Crossref] [PubMed]
  9. Heer EV, Harper AS, Sung H, Jemal A, Fidler-Benaoudia MM. Emerging cancer incidence trends in Canada: The growing burden of young adult cancers. Cancer 2020;126:4553-62. [Crossref] [PubMed]
  10. Yang L, Zheng R, Wang N, Yuan Y, Liu S, Li H, Zhang S, Zeng H, Chen W. Incidence and mortality of stomach cancer in China, 2014. Chin J Cancer Res 2018;30:291-8. [Crossref] [PubMed]
  11. Cuschieri A, Weeden S, Fielding J, Bancewicz J, Craven J, Joypaul V, Sydes M, Fayers P. Patient survival after D1 and D2 resections for gastric cancer: long-term results of the MRC randomized surgical trial. Surgical Co-operative Group. Br J Cancer 1999;79:1522-30. [Crossref] [PubMed]
  12. Songun I, Putter H, Kranenbarg EM, Sasako M, van de Velde CJ. Surgical treatment of gastric cancer: 15-year follow-up results of the randomised nationwide Dutch D1D2 trial. Lancet Oncol 2010;11:439-49. [Crossref] [PubMed]
  13. Wu CW, Hsiung CA, Lo SS, Hsieh MC, Chen JH, Li AF, Lui WY, Whang-Peng J. Nodal dissection for patients with gastric cancer: a randomised controlled trial. Lancet Oncol 2006;7:309-15. [Crossref] [PubMed]
  14. Gholami S, Janson L, Worhunsky DJ, Tran TB, Squires MH 3rd, Jin LX, Spolverato G, Votanopoulos KI, Schmidt C, Weber SM, Bloomston M, Cho CS, Levine EA, Fields RC, Pawlik TM, Maithel SK, Efron B, Norton JA, Poultsides GA. Number of Lymph Nodes Removed and Survival after Gastric Cancer Resection: An Analysis from the US Gastric Cancer Collaborative. J Am Coll Surg 2015;221:291-9. [Crossref] [PubMed]
  15. Kitano S, Iso Y, Moriyama M, Sugimachi K. Laparoscopy-assisted Billroth I gastrectomy. Surg Laparosc Endosc 1994;4:146-8.
  16. Tanaka C, Kanda M, Funasaka K, Miyahara R, Murotani K, Tanaka Y, Takeda S, Kobayashi D, Hirooka Y, Fujiwara M, Goto H, Kodera Y. Detection of indocyanine green fluorescence to determine tumor location during laparoscopic gastrectomy for gastric cancer: Results of a prospective study. Asian J Endosc Surg 2020;13:160-7. [Crossref] [PubMed]
  17. Sevick-Muraca EM. Translation of near-infrared fluorescence imaging technologies: emerging clinical applications. Annu Rev Med 2012;63:217-31.
  18. Reinhart MB, Huntington CR, Blair LJ, Heniford BT, Augenstein VA. Indocyanine Green: Historical Context, Current Applications, and Future Considerations. Surg Innov 2016;23:166-75. [Crossref] [PubMed]
  19. Feng LF, Yan PJ, Chu XJ, Zhang N, Li JY, Li JW, Guo KL, Lu CC, Li MX, Guo TK, Liu XR, Yang KH. A scientometric study of the top 100 most-cited publications based on Web-of-Science regarding robotic versus laparoscopic surgery. Asian J Surg 2021;44:440-51. [Crossref] [PubMed]
  20. Agarwal A, Baskaran S, Panner Selvam MK, Barbăroșie C, Master K. Unraveling the Footsteps of Proteomics in Male Reproductive Research: A Scientometric Approach. Antioxid Redox Signal 2020;32:536-49. [Crossref] [PubMed]
  21. Chen C, Song M. Visualizing a field of research: A methodology of systematic scientometric reviews. PLoS One 2019;14:e0223994. [Crossref] [PubMed]
  22. Cooper ID. Bibliometrics basics. J Med Libr Assoc 2015;103:217-8.
  23. Fang J, Pan L, Gu QX, Juengpanich S, Zheng JH, Tong CH, Wang ZY, Nan JJ, Wang YF. Scientometric analysis of mTOR signaling pathway in liver disease. Ann Transl Med 2020;8:93. [Crossref] [PubMed]
  24. Yang DW, Wang XP, Wang ZC, Yang ZH, Bian XF. A scientometric analysis on hepatocellular carcinoma magnetic resonance imaging research from 2008 to 2017. Quant Imaging Med Surg 2019;9:465-76. [Crossref] [PubMed]
  25. Zhong D, Luo S, Zheng L, Zhang Y, Jin R. Epilepsy Occurrence and Circadian Rhythm: A Bibliometrics Study and Visualization Analysis via CiteSpace. Front Neurol 2020;11:984. [Crossref] [PubMed]
  26. Li Y, Gao Q, Chen N, Zhang Y, Wang J, Li C, He X, Jiao Y, Zhang Z. Clinical studies of magnetic resonance elastography from 1995 to 2021: Scientometric and visualization analysis based on CiteSpace. Quant Imaging Med Surg 2022;12:5080-100. [Crossref] [PubMed]
  27. Liu B, Zhang D, Wang H, Wang H, Zhang P, Zhang D, Zhang Q, Zhang J. The predictive potential of contrast-enhanced computed tomography based radiomics in the preoperative staging of cT4 gastric cancer. Quant Imaging Med Surg 2022;12:5222-38. [Crossref] [PubMed]
  28. Chen C. Science Mapping: A Systematic Review of the Literature. Journal of Data and Information Science 2017;2:1-40.
  29. de Solla Price D. Editorial statements. Scientometrics 1978;1:3-8.
  30. Zhou Q, Wu F, Zhao M, Yang M. Bibliometric Evaluation of 2012-2020 Publications on Ferroptosis in Cancer Treatment. Front Cell Dev Biol 2021;9:793347. [Crossref] [PubMed]
  31. Deng Z, Qiao G, Ma L, Zhang Q, Zhang P, Cui D. Photosensitizer-Functionalized Mn@Co Magnetic Nanoparticles for MRI/NIR-Mediated Photothermal Therapy of Gastric Cancer. ACS Appl Nano Mater 2021;4:13523-33.
  32. Lu X, Liu S, Xia X, Sun F, Liu Z, Wang J, Li X, Yang Z, Kang X, Ai S, Guan W. The short-term and long-term outcomes of indocyanine green tracer-guided laparoscopic radical gastrectomy in patients with gastric cancer. World J Surg Oncol 2021;19:271. [Crossref] [PubMed]
  33. Park JH, Berlth F, Wang C, Wang S, Choi JH, Park SH, Suh YS, Kong SH, Park DJ, Lee HJ, Kwak Y, Kim WH, Yang HK. Mapping of the perigastric lymphatic network using indocyanine green fluorescence imaging and tissue marking dye in clinically advanced gastric cancer. Eur J Surg Oncol 2022;48:411-7. [Crossref] [PubMed]
  34. Kiyuna T, Tome Y, Uehara F, Murakami T, Zhang Y, Zhao M, Kanaya F, Hoffman RM. Tumor-targeting Salmonella typhimurium A1-R Inhibits Osteosarcoma Angiogenesis in the In Vivo Gelfoam® Assay Visualized by Color-coded Imaging. Anticancer Res 2018;38:159-64. [Crossref] [PubMed]
  35. Guo J, Miao Y, Xiao B, Huan R, Jiang Z, Meng D, Wang Y. Differential expression of microRNA species in human gastric cancer versus non-tumorous tissues. J Gastroenterol Hepatol 2009;24:652-7. [Crossref] [PubMed]
  36. Schaafsma BE, Mieog JS, Hutteman M, van der Vorst JR, Kuppen PJ, Löwik CW, Frangioni JV, van de Velde CJ, Vahrmeijer AL. The clinical use of indocyanine green as a near-infrared fluorescent contrast agent for image-guided oncologic surgery. J Surg Oncol 2011;104:323-32. [Crossref] [PubMed]
  37. Hofmann M, Stoss O, Shi D, Büttner R, van de Vijver M, Kim W, Ochiai A, Rüschoff J, Henkel T. Assessment of a HER2 scoring system for gastric cancer: results from a validation study. Histopathology 2008;52:797-805. [Crossref] [PubMed]
  38. Garfield E. The history and meaning of the journal impact factor. JAMA 2006;295:90-3.
  39. Lu C, Liu M, Shang W, Yuan Y, Li M, Deng X, Li H, Yang K. Knowledge Mapping of Angelica sinensis (Oliv.) Diels (Danggui) Research: A Scientometric Study. Front Pharmacol 2020;11:294. [Crossref] [PubMed]
  40. Bang YJ, Van Cutsem E, Feyereislova A, Chung HC, Shen L, Sawaki A, Lordick F, Ohtsu A, Omuro Y, Satoh T, Aprile G, Kulikov E, Hill J, Lehle M, Rüschoff J, Kang YK. ToGA Trial Investigators. Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial. Lancet 2010;376:687-97. [Crossref] [PubMed]
  41. Lan YT, Huang KH, Chen PH, Liu CA, Lo SS, Wu CW, Shyr YM, Fang WL. A pilot study of lymph node mapping with indocyanine green in robotic gastrectomy for gastric cancer. SAGE Open Med 2017;5:2050312117727444. [Crossref] [PubMed]
  42. Huh YJ, Lee HJ, Kim TH, Choi YS, Park JH, Son YG, Suh YS, Kong SH, Yang HK. Efficacy of Assessing Intraoperative Bowel Perfusion with Near-Infrared Camera in Laparoscopic Gastric Cancer Surgery. J Laparoendosc Adv Surg Tech A 2019;29:476-83. [Crossref] [PubMed]
  43. Kwon IG, Son T, Kim HI, Hyung WJ. Fluorescent Lymphography-Guided Lymphadenectomy During Robotic Radical Gastrectomy for Gastric Cancer. JAMA Surg 2019;154:150-8. [Crossref] [PubMed]
  44. Rüschoff J, Hanna W, Bilous M, Hofmann M, Osamura RY, Penault-Llorca F, van de Vijver M, Viale G. HER2 testing in gastric cancer: a practical approach. Mod Pathol 2012;25:637-50. [Crossref] [PubMed]
  45. Hiratsuka M, Miyashiro I, Ishikawa O, Furukawa H, Motomura K, Ohigashi H, Kameyama M, Sasaki Y, Kabuto T, Ishiguro S, Imaoka S, Koyama H. Application of sentinel node biopsy to gastric cancer surgery. Surgery 2001;129:335-40. [Crossref] [PubMed]
  46. Ito S, Muguruma N, Kusaka Y, Tadatsu M, Inayama K, Musashi Y, Yano M, Bando T, Honda H, Shimizu I, Ii K, Takesako K, Takeuchi H, Shibamura S. Detection of human gastric cancer in resected specimens using a novel infrared fluorescent anti-human carcinoembryonic antigen antibody with an infrared fluorescence endoscope in vitro. Endoscopy 2001;33:849-53. [Crossref] [PubMed]
  47. Wang Z, Ma D, Pang R, Xie F, Zhang J, Sun D. Research Progress and Development Trend of Social Media Big Data (SMBD): Knowledge Mapping Analysis Based on CiteSpace. ISPRS Int J Geo-Inf 2020;9:632.
  48. Butt NS, Malik AA, Shahbaz MQ. Bibliometric Analysis of Statistics Journals Indexed in Web of Science Under Emerging Source Citation Index. Sage Open 2021;11:1. [Crossref] [PubMed]
  49. He M, Jiang Z, Wang C, Hao Z, An J, Shen J. Diagnostic value of near-infrared or fluorescent indocyanine green guided sentinel lymph node mapping in gastric cancer: A systematic review and meta-analysis. J Surg Oncol 2018;118:1243-56. [Crossref] [PubMed]
  50. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2018;68:394-424. [Crossref] [PubMed]
  51. Huang C, Liu H, Hu Y, Sun Y, Su X, Cao H, et al. Laparoscopic vs Open Distal Gastrectomy for Locally Advanced Gastric Cancer: Five-Year Outcomes From the CLASS-01 Randomized Clinical Trial. JAMA Surg 2022;157:9-17. [Crossref] [PubMed]
  52. Kamada T, Ohdaira H, Nakashima K, Nishide R, Nishie R, Takahashi J, Ito E, Nakaseko Y, Suzuki N, Yoshida M, Sumi M, Suzuki Y. Real-time vessel navigation using indocyanine green fluorescence during robotic-assisted gastrectomy for gastric cancer after coronary artery bypass grafting using the right gastroepiploic artery. Asian J Endosc Surg 2023;16:533-6. [Crossref] [PubMed]
  53. Cho M, Kim KY, Park SH, Kim YM, Kim HI, Hyung WJ. Securing Resection Margin Using Indocyanine Green Diffusion Range on Gastric Wall during NIR Fluorescence-Guided Surgery in Early Gastric Cancer Patients. Cancers (Basel) 2022.
  54. Dong B, Zhang A, Zhang Y, Ye W, Liao L, Li Z. Efficacy of indocyanine green fluorescence imaging-guided lymphadenectomy in radical gastrectomy for gastric cancer: A systematic review and meta-analysis. Front Oncol 2022;12:998159. [Crossref] [PubMed]
  55. Chen QY, Xie JW, Zhong Q, Wang JB, Lin JX, Lu J, Cao LL, Lin M, Tu RH, Huang ZN, Lin JL, Zheng HL, Li P, Zheng CH, Huang CM. Safety and Efficacy of Indocyanine Green Tracer-Guided Lymph Node Dissection During Laparoscopic Radical Gastrectomy in Patients With Gastric Cancer: A Randomized Clinical Trial. JAMA Surg 2020;155:300-11. [Crossref] [PubMed]
  56. Lombardi PM, Mazzola M, Nicastro V, Giacopuzzi S, Baiocchi GL, Castoro C, Rosati R, Fumagalli Romario U, Bonavina L, Staderini F, Gockel I, Gregori D, De Martini P, Gualtierotti M, Danieli M, Beretta S, Mutignani M, Forti E, Ferrari G. The iGreenGO Study: The Clinical Role of Indocyanine Green Imaging Fluorescence in Modifying the Surgeon's Conduct During the Surgical Treatment of Advanced Gastric Cancer-Study Protocol for an International Multicenter Prospective Study. Front Oncol 2022;12:854754. [Crossref] [PubMed]
  57. Hwang Y, Yoon H, Choe K, Ahn J, Jung JH, Park JH, Kim P. In vivo cellular-level real-time pharmacokinetic imaging of free-form and liposomal indocyanine green in liver. Biomed Opt Express 2017;8:4706-16. [Crossref] [PubMed]
  58. Zhang C, Zhao Y, Zhang H, Chen X, Zhao N, Tan D, Zhang H, Shi C. The Application of Heptamethine Cyanine Dye DZ-1 and Indocyanine Green for Imaging and Targeting in Xenograft Models of Hepatocellular Carcinoma. Int J Mol Sci 2017;18:1332. [Crossref] [PubMed]
  59. Miyashiro I, Hiratsuka M, Sasako M, Sano T, Mizusawa J, Nakamura K, Nashimoto A, Tsuburaya A, Fukushima N. High false-negative proportion of intraoperative histological examination as a serious problem for clinical application of sentinel node biopsy for early gastric cancer: final results of the Japan Clinical Oncology Group multicenter trial JCOG0302. Gastric Cancer 2014;17:316-23. [Crossref] [PubMed]
  60. Shao J, Zheng X, Feng L, Lan T, Ding D, Cai Z, Zhu X, Liang R, Wei B. Targeting Fluorescence Imaging of RGD-Modified Indocyanine Green Micelles on Gastric Cancer. Front Bioeng Biotechnol 2020;8:575365. [Crossref] [PubMed]
  61. Belia F, Biondi A, Agnes A, Santocchi P, Laurino A, Lorenzon L, Pezzuto R, Tirelli F, Ferri L, D'Ugo D, Persiani R. The Use of Indocyanine Green (ICG) and Near-Infrared (NIR) Fluorescence-Guided Imaging in Gastric Cancer Surgery: A Narrative Review. Front Surg 2022;9:880773.
Cite this article as: Zhang G, Zhang Y, Zhang Y, Zhao W, Xia Y, Song J, Feng Z, Liu L, Shu X, Wu A, Wu Y, Cao Y, Jie Z, Li Z. Global trends in indocyanine green fluorescence navigation in the field of gastric cancer: bibliometrics and knowledge atlas analysis. Quant Imaging Med Surg 2023;13(10):7117-7141. doi: 10.21037/qims-23-391

Download Citation